Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Cystadenocarcinoma and TP53[original query] |
|---|
| Mutational heterogeneity in non-serous ovarian cancers. Scientific reports 2017 Aug 7 (1): 9728. Teer Jamie K, Yoder Sean, Gjyshi Anxhela, Nicosia Santo V, Zhang Chaomei, Monteiro Alvaro N |
| TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database. Journal of cancer research and clinical oncology 2018 12 145 (3): 625-636. Li Victor D, Li Karen H, Li John |
| Low-grade Apocrine Intraductal Carcinoma: Expanding the Morphologic and Molecular Spectrum of an Enigmatic Salivary Gland Tumor. Head and neck pathology 2020 1 14 (4): 869-875. Bishop Justin A, Gagan Jeffrey, Krane Jeffrey F, Jo Vickie |
| Assessment of Significant Pathway Signaling and Prognostic Value of GNG11 in Ovarian Serous Cystadenocarcinoma. International journal of general medicine 2021 14 2329-2341. Jiang Ming-Min, Zhao Fan, Lou Tao-T |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: